Information Request Form

Section:	Main.INFLUENZA VIRUS.Infection. Treatment.Respiratory Congestion Redn..Neuraminidase Inhibitor..H1 Histamine R Antagonist Combi..Oseltamivir.+.H1 Histamine R Antagonist Combi..Patent..Claims.Claim 1: Dual Release Drug Delivery.Device: 1) Compn.: Oseltamivir &.Excipient; Controlled Release & 2).H1 Histamine Receptor Antagonist;.Rapid Release. Claim 2: Device.Select: Capsules Etc. Claim 4:.(1): Release Rate Modifier. Claim 5.: (2): Excipient. Claim 12: Osmotic.Device: a) Core: Oseltamivir (Granu.late) & Osmotic Agent; b) SemiPerme.able Membrane having Passageway.& c) Coat.: H1 Antagonist. Claim.13: Inert Water Soluble Coat (d).between (b) & (c). Claim 14: (c).Sprayed onto (d). Claim 19:.H1 Antagonist Select: Acrivastine;.Fexofenadine, Loratadine Etc..Claim 24: Core: OsmAgent; Binder &.Diluent. Membrane: Cellulose Ester.& Plasticizer. (d): Water Soluble.Polymer; Opaquant & Filler. (c):.Film Forming Polymer & DisIntegrant.. Claim 25: OsmAgent: NaCl Etc..Diluent: MicroCrystalline Cellulose.Etc. Binder: Poly(VinylPyrrolidone).Etc. Cellulose Acetate (Ester) Etc..Plasticizer: Poly(Ethylene Glycol).Etc. Water Soluble Polymer:.HydroxyPr MeCellulose Etc..Opaquant: TiO2 Etc. Filler: Talc..Film Forming Polymer:.hydroxyPr MeCellulose Etc..DisIntegrant: CrosPovidone Etc..Claim 28: Viral Infection Treat. &.Respiratory Congestion Redn. Method.. Patent Assignee
Code:	56351
Product:	VG. O
Company or Organization:
Contact's name *:
Position:
E-mail:
Mailing address:
Phone number:
Fax number:
Fields of interest:	PATENT ASSIGNEE PATENT INVENTORS PATENT NUMBER
* If you are not linked to any company or organization complete at least this field